Tigan suppositories removed from market
Trimethobenzamide-containing suppositories are the next product in line to hit the FDA's chopping block as part of the agency's ongoing effort to ensure that all marketed drugs have been officially approved. The rectally administered treatment of nausea and vomiting has been available under the brand names Tigan, Tebamide, Trimazide, Trimethobenz, and T-Gen.
Recent Videos
Related Content
